Increased plasma pancreatic polypeptide in chronic alcohol abuse

Area of Science:

• Gastroenterology
• Endocrinology
• Alcohol-related research

Background:

• Chronic alcohol abuse is frequently associated with pancreatic dysfunction.
• Gastrointestinal hormone profiles in alcoholics require further investigation, particularly during withdrawal.

Purpose of the Study:

• To investigate post-prandial plasma gastrointestinal hormone profiles in chronic alcoholics.
• To assess changes in hormone levels one and fourteen days after alcohol withdrawal.

Main Methods:

• Measured basal and post-prandial plasma concentrations of pancreatic polypeptide (PP), gastrin, gastric inhibitory peptide, insulin, and glucagon.
• Included nine chronic alcoholics and a control group.
• Assessed hormone levels at baseline, one day, and fourteen days post-alcohol withdrawal.

Main Results:

• Significantly elevated basal and integrated total response (TIR) of pancreatic polypeptide (PP) were observed in alcoholics compared to controls, persisting up to 14 days after withdrawal.
• No significant differences in basal or TIR levels of gastrin, gastric inhibitory peptide, insulin, or glucagon were found between alcoholics and controls.
• Alcoholics exhibited higher PP concentrations post-withdrawal (Day 1: 62 ± 14 pmol/l; Day 14: 89 ± 17 pmol/l) compared to controls (28 ± 5 pmol/l).

Conclusions:

• Elevated pancreatic polypeptide (PP) levels in chronic alcoholics persist after withdrawal.
• These hormonal alterations may contribute to the commonly observed pancreatic exocrine dysfunction in alcoholics.
• Further research is warranted to elucidate the precise mechanisms linking alcohol abuse, PP dysregulation, and pancreatic pathology.